Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CNC
CNC logo

CNC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Centene Corp (CNC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
32.370
1 Day change
1.79%
52 Week Range
66.030
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Centene Corp (CNC) is not a good buy for a beginner, long-term investor at this time. The technical indicators, financial performance, and analyst sentiment suggest caution. The stock has shown weak financial results, limited positive catalysts, and no strong trading signals to suggest an immediate entry point.

Technical Analysis

The MACD is below 0 and negatively contracting, indicating bearish momentum. RSI is neutral at 34.331, and moving averages are converging, suggesting no clear trend. The stock is trading near key support at S1: 32.335, with resistance at R1: 36.369. Overall, technical indicators do not signal a strong buying opportunity.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
4

Positive Catalysts

  • Centene Corp is involved in affordable housing projects, which may improve its public image and long-term growth potential.

Neutral/Negative Catalysts

  • Recent financial performance shows a significant decline in net income (-489.05% YoY) and EPS (-500.00% YoY). Analysts have lowered price targets, citing uncertainty in Medicaid and Affordable Care Act exchange enrollment. The stock has also experienced a 16% selloff recently, reflecting investor concerns.

Financial Performance

In Q4 2025, revenue increased by 21.86% YoY to $49.725 billion. However, net income dropped to -$1.101 billion (-489.05% YoY), EPS fell to -2.24 (-500.00% YoY), and gross margin declined to 4.3% (-48.50% YoY). These results indicate significant profitability challenges.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are mixed to negative on the stock. JPMorgan, Goldman Sachs, and Mizuho have lowered price targets, citing near-term uncertainty and risks in Medicaid and ACA exchanges. Truist and Bernstein are more optimistic but acknowledge challenges. The consensus reflects a cautious outlook with limited upside potential.

Wall Street analysts forecast CNC stock price to rise
15 Analyst Rating
Wall Street analysts forecast CNC stock price to rise
5 Buy
8 Hold
2 Sell
Hold
Current: 31.800
sliders
Low
32
Averages
43.07
High
59
Current: 31.800
sliders
Low
32
Averages
43.07
High
59
JPMorgan
John Stansel
Neutral
downgrade
$45 -> $41
AI Analysis
2026-03-19
Reason
JPMorgan
John Stansel
Price Target
$45 -> $41
AI Analysis
2026-03-19
downgrade
Neutral
Reason
JPMorgan analyst John Stansel lowered the firm's price target on Centene to $41 from $45 and keeps a Neutral rating on the shares. The firm says the stock's 16% selloff in the past week is a reminder that Managed Medicaid "remains the subsection of managed care (and perhaps healthcare services) with the widest error bars in 2026." JPMorgan lowered Centene's estimates to reflect near-term uncertainty and assumed 2027 Affordable Care Act exchange enrollment contraction.
Goldman Sachs
Sell
downgrade
$38 -> $32
2026-03-13
Reason
Goldman Sachs
Price Target
$38 -> $32
2026-03-13
downgrade
Sell
Reason
Goldman Sachs lowered the firm's price target on Centene to $32 from $38 and keeps a Sell rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CNC
Unlock Now

People Also Watch